Xu YY - Search Results

1

Combined Single-Cell and Spatial Transcriptomics Reveal the Metabolic Evolvement of Breast Cancer during Early Dissemination.

Liu YM, Ge JY, Chen YF, Liu T, Chen L, Liu CC, Ma D, Chen YY, Cai YW, Xu YY, Shao ZM, Yu KD. Liu YM, et al. Among authors: xu yy. Adv Sci (Weinh). 2023 Feb;10(6):e2205395. doi: 10.1002/advs.202205395. Epub 2023 Jan 3. Adv Sci (Weinh). 2023. PMID: 36594618 Free PMC article.

2

Impact of hormone receptor, HER2, and Ki-67 status conversions on survival after neoadjuvant chemotherapy in breast cancer patients: a retrospective study.

Chen Y, Liu X, Yu K, Sun X, Xu S, Qiu P, Lv Z, Zhang X, Guo A, Xu Y. Chen Y, et al. Ann Transl Med. 2022 Jan;10(2):93. doi: 10.21037/atm-21-6924. Ann Transl Med. 2022. PMID: 35282081 Free PMC article.

3

Resistance to antibody-drug conjugates in breast cancer: mechanisms and solutions.

Chen YF, Xu YY, Shao ZM, Yu KD. Chen YF, et al. Among authors: xu yy. Cancer Commun (Lond). 2023 Mar;43(3):297-337. doi: 10.1002/cac2.12387. Epub 2022 Nov 10. Cancer Commun (Lond). 2023. PMID: 36357174 Free PMC article. Review.

4

A generalized non-linear model predicting efficacy of neoadjuvant therapy in HER2+ breast cancer.

Wang Y, Liu X, Yu K, Xu S, Qiu P, Zhang X, Wang M, Xu Y. Wang Y, et al. iScience. 2023 Mar 2;26(4):106330. doi: 10.1016/j.isci.2023.106330. eCollection 2023 Apr 21. iScience. 2023. PMID: 36950120 Free PMC article.

5

Metabolic Reprogramming in Triple-Negative Breast Cancer.

Sun X, Wang M, Wang M, Yu X, Guo J, Sun T, Li X, Yao L, Dong H, Xu Y. Sun X, et al. Front Oncol. 2020 Mar 31;10:428. doi: 10.3389/fonc.2020.00428. eCollection 2020. Front Oncol. 2020. PMID: 32296646 Free PMC article. Review.

6

Exploring the Metabolic Vulnerabilities of Epithelial-Mesenchymal Transition in Breast Cancer.

Sun X, Wang M, Wang M, Yao L, Li X, Dong H, Li M, Li X, Liu X, Xu Y. Sun X, et al. Front Cell Dev Biol. 2020 Jul 24;8:655. doi: 10.3389/fcell.2020.00655. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32793598 Free PMC article. Review.

7

Comparison of three lymph node staging methods for predicting outcome in breast cancer patients with mastectomy.

Wang MS, Wang MZ, Wang Z, Song Y, Gao P, Wang P, Wang C, Yu X, Wei F, Guo J, Xu Y. Wang MS, et al. Ann Transl Med. 2021 Feb;9(4):300. doi: 10.21037/atm-20-4856. Ann Transl Med. 2021. PMID: 33708927 Free PMC article.

8

Transforming growth factor-beta1 signaling blockade attenuates gastric cancer cell-induced peritoneal mesothelial cell fibrosis and alleviates peritoneal dissemination both in vitro and in vivo.

Miao ZF, Zhao TT, Wang ZN, Miao F, Xu YY, Mao XY, Gao J, Wu JH, Liu XY, You Y, Xu H, Xu HM. Miao ZF, et al. Among authors: xu yy, xu hm, xu h. Tumour Biol. 2014 Apr;35(4):3575-83. doi: 10.1007/s13277-013-1472-x. Epub 2013 Dec 18. Tumour Biol. 2014. PMID: 24347485

9

Endoglin overexpression mediates gastric cancer peritoneal dissemination by inducing mesothelial cell senescence.

Miao ZF, Wu JH, Wang ZN, Zhao TT, Xu HM, Song YX, Xing YN, Huang JY, Zhang JY, Liu XY, Xu H, Xu YY. Miao ZF, et al. Among authors: xu yy, xu hm, xu h. Hum Pathol. 2016 May;51:114-23. doi: 10.1016/j.humpath.2015.12.023. Epub 2016 Jan 19. Hum Pathol. 2016. PMID: 27067789

10

Mechanism of immune evasion in breast cancer.

Wang M, Zhang C, Song Y, Wang Z, Wang Y, Luo F, Xu Y, Zhao Y, Wu Z, Xu Y. Wang M, et al. Onco Targets Ther. 2017 Mar 14;10:1561-1573. doi: 10.2147/OTT.S126424. eCollection 2017. Onco Targets Ther. 2017. PMID: 28352189 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,037 results

Search Page